Matches in SemOpenAlex for { <https://semopenalex.org/work/W2055714934> ?p ?o ?g. }
Showing items 1 to 72 of
72
with 100 items per page.
- W2055714934 endingPage "757" @default.
- W2055714934 startingPage "756" @default.
- W2055714934 abstract "Hereditary inclusion body myopathy type 2 (HIBM2) or GNE Myopathy is associated with mutations in the GNE gene that encodes the bifunctional protein essential for sialic acid biosynthesis, UDP-GlcNAc 2-epimerase/N-acetylmannosamine kinase. Whether mutations in GNE or other genes within the sialic acid pathway are associated with hereditary or sporadic muscle diseases such as sporadic inclusion body myositis (sIBM) is not known. More importantly whether these disorders will be amenable to oral sialic acid treatment is not established. We performed targeted next generation sequencing of the whole GNE locus and the coding regions of three other genes essential for sialic acid synthesis (NANS N-acetylneuraminic acid phosphate synthase; NANP Neu5Ac-9-phosphate phosphatase; CMAS CMP-Neu5Ac synthetase) that have not previously been reported to be associated with muscle disease in 78 patients with sIBM and 9 patients with presumed HIBM. Using this strategy, we identified compound heterozygous mutations in the GNE gene in 5 of 9 HIBM patients, one of which was novel. Interestingly, two of these patients had been previously characterized as sIBM despite being siblings, two were referred for spinal muscular atrophy, and one with an undiagnosed HIBM. Moreover, two of these five patients had been previously reported to be sequenced for GNE mutations and found to be negative. The minor allele of two GNE intronic SNPs was statistically overrepresented in our cohort compared to population controls. Of the 78 sIBM patients, one was heterozygous for a rare missense variant in GNE and three were heterozygous for rare missense variants in NANS. Coding mutations in GNE, NANS, NANP and CMAS are rare in sIBM patients. Any patient with a family history of sIBM or clinical suspicion in the setting of negative genetic testing should be tested/retested for GNE mutations. Next generation sequencing may identify mutations previously undetected by traditional sequencing methods. Hereditary inclusion body myopathy type 2 (HIBM2) or GNE Myopathy is associated with mutations in the GNE gene that encodes the bifunctional protein essential for sialic acid biosynthesis, UDP-GlcNAc 2-epimerase/N-acetylmannosamine kinase. Whether mutations in GNE or other genes within the sialic acid pathway are associated with hereditary or sporadic muscle diseases such as sporadic inclusion body myositis (sIBM) is not known. More importantly whether these disorders will be amenable to oral sialic acid treatment is not established. We performed targeted next generation sequencing of the whole GNE locus and the coding regions of three other genes essential for sialic acid synthesis (NANS N-acetylneuraminic acid phosphate synthase; NANP Neu5Ac-9-phosphate phosphatase; CMAS CMP-Neu5Ac synthetase) that have not previously been reported to be associated with muscle disease in 78 patients with sIBM and 9 patients with presumed HIBM. Using this strategy, we identified compound heterozygous mutations in the GNE gene in 5 of 9 HIBM patients, one of which was novel. Interestingly, two of these patients had been previously characterized as sIBM despite being siblings, two were referred for spinal muscular atrophy, and one with an undiagnosed HIBM. Moreover, two of these five patients had been previously reported to be sequenced for GNE mutations and found to be negative. The minor allele of two GNE intronic SNPs was statistically overrepresented in our cohort compared to population controls. Of the 78 sIBM patients, one was heterozygous for a rare missense variant in GNE and three were heterozygous for rare missense variants in NANS. Coding mutations in GNE, NANS, NANP and CMAS are rare in sIBM patients. Any patient with a family history of sIBM or clinical suspicion in the setting of negative genetic testing should be tested/retested for GNE mutations. Next generation sequencing may identify mutations previously undetected by traditional sequencing methods." @default.
- W2055714934 created "2016-06-24" @default.
- W2055714934 creator A5006551650 @default.
- W2055714934 creator A5006583782 @default.
- W2055714934 creator A5013665161 @default.
- W2055714934 creator A5018367541 @default.
- W2055714934 creator A5025781296 @default.
- W2055714934 creator A5031506785 @default.
- W2055714934 creator A5040942918 @default.
- W2055714934 creator A5084599209 @default.
- W2055714934 creator A5090973240 @default.
- W2055714934 date "2013-10-01" @default.
- W2055714934 modified "2023-09-26" @default.
- W2055714934 title "P.3.5 Identification of rare variants in GNE and other sialic biosynthetic genes in HIBM2 and sIBM" @default.
- W2055714934 doi "https://doi.org/10.1016/j.nmd.2013.06.430" @default.
- W2055714934 hasPublicationYear "2013" @default.
- W2055714934 type Work @default.
- W2055714934 sameAs 2055714934 @default.
- W2055714934 citedByCount "0" @default.
- W2055714934 crossrefType "journal-article" @default.
- W2055714934 hasAuthorship W2055714934A5006551650 @default.
- W2055714934 hasAuthorship W2055714934A5006583782 @default.
- W2055714934 hasAuthorship W2055714934A5013665161 @default.
- W2055714934 hasAuthorship W2055714934A5018367541 @default.
- W2055714934 hasAuthorship W2055714934A5025781296 @default.
- W2055714934 hasAuthorship W2055714934A5031506785 @default.
- W2055714934 hasAuthorship W2055714934A5040942918 @default.
- W2055714934 hasAuthorship W2055714934A5084599209 @default.
- W2055714934 hasAuthorship W2055714934A5090973240 @default.
- W2055714934 hasConcept C104317684 @default.
- W2055714934 hasConcept C12125453 @default.
- W2055714934 hasConcept C157410074 @default.
- W2055714934 hasConcept C180754005 @default.
- W2055714934 hasConcept C2780115458 @default.
- W2055714934 hasConcept C37463918 @default.
- W2055714934 hasConcept C501734568 @default.
- W2055714934 hasConcept C54355233 @default.
- W2055714934 hasConcept C75563809 @default.
- W2055714934 hasConcept C84597430 @default.
- W2055714934 hasConcept C86803240 @default.
- W2055714934 hasConceptScore W2055714934C104317684 @default.
- W2055714934 hasConceptScore W2055714934C12125453 @default.
- W2055714934 hasConceptScore W2055714934C157410074 @default.
- W2055714934 hasConceptScore W2055714934C180754005 @default.
- W2055714934 hasConceptScore W2055714934C2780115458 @default.
- W2055714934 hasConceptScore W2055714934C37463918 @default.
- W2055714934 hasConceptScore W2055714934C501734568 @default.
- W2055714934 hasConceptScore W2055714934C54355233 @default.
- W2055714934 hasConceptScore W2055714934C75563809 @default.
- W2055714934 hasConceptScore W2055714934C84597430 @default.
- W2055714934 hasConceptScore W2055714934C86803240 @default.
- W2055714934 hasIssue "9-10" @default.
- W2055714934 hasLocation W20557149341 @default.
- W2055714934 hasOpenAccess W2055714934 @default.
- W2055714934 hasPrimaryLocation W20557149341 @default.
- W2055714934 hasRelatedWork W1970327593 @default.
- W2055714934 hasRelatedWork W1975253683 @default.
- W2055714934 hasRelatedWork W1993967715 @default.
- W2055714934 hasRelatedWork W2005183124 @default.
- W2055714934 hasRelatedWork W2031464773 @default.
- W2055714934 hasRelatedWork W2057739827 @default.
- W2055714934 hasRelatedWork W2187386201 @default.
- W2055714934 hasRelatedWork W3189132110 @default.
- W2055714934 hasRelatedWork W4287398924 @default.
- W2055714934 hasRelatedWork W64331312 @default.
- W2055714934 hasVolume "23" @default.
- W2055714934 isParatext "false" @default.
- W2055714934 isRetracted "false" @default.
- W2055714934 magId "2055714934" @default.
- W2055714934 workType "article" @default.